Medical News Today: Gene mutation may be a key to lung cancer treatment
Medical News Today highlighted University of Cincinnati research recently published in the journal Nature Communications that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.
The research focused on lung cancer with a mutated KRAS gene, an oncogene that works as a gas pedal to help cancer cells grow. The team found that lung cancer with the KRAS gene had a unique lipid profile and was dependent on an enzyme called FASN that is involved in fatty acid synthesis.
The researchers found that blocking FASN promoted the death of specific lung cancer cells. Pier Paolo Scaglioni, MD, corresponding author on the study, told Medical News Today there are exciting potential treatments that could come as a result of this research.
"There is a great interest in developing drugs that target the metabolisms of cancer cells. Thus, yes, there are therapeutic implications," said Scaglioni, associate director for translational research at the University of Cincinnati Cancer Center, professor and division chief of hematology oncology in the Department of Internal Medicine in UC’s College of Medicine and a UC Health physician. "We have carried out a phase I trial with a FASN inhibitor and are performing a phase II trial in lung cancer patients with the KRAS mutation.”
Read the Medical News Today article.
Read more about Scaglioni's research.
Featured photo at top of Dr. Scaglioni with a patient courtesy of UC Health.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.